Phosphorylation of the immunomodulator fty720 inhibits programmed cell death of fibroblasts via the s1p 3 receptor subtype and bcl-2 activation

Cellular Physiology and Biochemistry

Volumn 26, Issue 1, 2010, Pages 67-78

  Potteck, Henrik ^a   Nieuwenhuis, Barbara ^b   Lüth, Anja ^a   Van Der Giet, Markus ^c   Kleuser, Burkhard ^a,b  

^a UNIVERSITY OF POTSDAM   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Bcl 2; Fibroblasts; FTY720; Mitochondria; S1P 3

Indexed keywords

FINGOLIMOD; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2; PROTEIN KINASE B; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1 PHOSPHATE RECEPTOR 3; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKIN FIBROBLAST;

ISARIA SINCLAIRII;

EID: 77952937151     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000315107     Document Type: Article

References (65)

1. Kappos L, Antel J, Comi G, Montalban X, O'Connor P, Polman CH, Haas T, Korn AA, Karlsson G, Radue EW: Oral fingolimod (FTY720) for relapsing multiple sclerosis. N Engl J Med 2006;355:1124-1140.
2. Brinkmann V, Davis MD, Heise CE, Albert R, Cottens S, Hof R, Bruns C, Prieschl E, Baumruker T, Hiestand P, Foster CA, Zollinger M, Lynch KR: The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 2002;277:21453-21457.
3. Mandala S, Hajdu R, Bergstrom J, Quackenbush E, Xie J, Milligan J, Thornton R, Shei GJ, Card D, Keohane C, Rosenbach M, Hale J, Lynch CL, Rupprecht K, Parsons W, Rosen H: Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 2002;296:346-349.
4. Rosen H, Sanna G, Alfonso C: Egress: a receptor-regulated step in lymphocyte trafficking. Immunol Rev 2003;195:160-177.
5. Sanna MG, Wang SK, Gonzales-Cabrera PJ, Don A, Marsolais D, MAtheu MP, Wei SH, Parker I, Jo, E, Cheng WC, Cahalan MD, Wong CH, Rosen H: Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. Nat Chem Biol 2006;2:434-441.
6. Hla T: Sphingosine 1-phosphate receptors. Prostaglandins 2001;64:135-142.
7. Nixon GF: Sphingolipids in inflammation: pathological implications and potential therapeutic targets. Br J Pharmacol 2009;158:982-993.
8. Matloubian M, LO CG, Cinamon G, Lesneki MJ, Yu Y, Brinkmann V, Allende ML, Proia RL, Cyster JG: Lymphocyte egress from thymus and peripheral lym-phoid organs is dependent on S1P receptor 1. Nature 2004;427:355-360.
9. von Wenckstern H, Zimmermann K, Kleuser B: The role of the lysophospholipid sphingosine 1-phos-phate in immune cell biology. Arch Immunol Ther Exp (Warsz) 2006;54:239-251.
10. Lawen A: Apoptosis-an introduction. Bioessays 2003;25:888-896.
11. Shimizu S, Narita M, Tsujimoto Y: Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mito-chondrial channel VDAC. Nature 1999;399:483-487.
12. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD: The release of cyto-chrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997;275:1132-1136.
13. Wong RC, Tellis I, Jamshidi P, Pera M, Pebay A: Anti-apoptotic effect of sphin-gosine-1-phosphate and platelet-derived growth factor in human embryonic stem cells. Stem Cells Dev 2007;16:989-1001.
14. Maeurer C, Holland S, Pierre S, Potstada W, Scholich K: Sphingosine-1-phosphate induced mTOR-activation is mediated by the E3-ubiquitin ligase PAM. Cell Signal 2009;21:293-300.
15. Sauer B, Gonska H, Manggau M, Kim DS, Schraut C, Schafer-Korting M, Kleuser B: Sphingosine 1-phosphate is involved in cytoprotective actions of calcitriol in human fibroblasts and enhances the intracellular Bcl-2/Bax rheostat. Pharmazie 2005;60:298-304.
16. Donati C, Cencetti F, Nincheri P, Bernacchioni C, Brunelli S, Clementi E, Cossu G, Bruni P: Sphingosine 1-phos-phate mediates proliferation and survival of mesoangioblasts. Stem Cells 2007;25:1713-1719.
17. Nieuwenhuis B, Luth A, Chun J, Huwiler A, Pfeilschifter J, Schafer-Korting M, Kleuser B: Involvement of the ABC-transporter ABCC1 and the sphingosine 1-phosphate receptor subtype S1P(3) in the cytoprotection of human fibroblasts by the glucocorticoid dexamethasone. J Mol Med 2009;87:645-657.
18. Hofmann U, Burkard N, Vogt C, Thoma A, Frantz S, Ertl G, Ritter O, Bonz A: Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion. Cardiovasc Res 2009;83:285-293.
19. Miron VE, Hall JA, Kennedy TE, Soliven B, Antel JP: Cyclical and dose-dependent responses of adult human mature oligodendrocytes to fingolimod. Am J Pathol 2008;173:1143-1152.
20. Hung JH, Lu YS, Wang YC, Ma YH, Wang DS, Kulp SK, Muthusamy N, Byrd JC, Cheng AL, Chen CS: FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein ki-nase C delta signaling. Cancer Res 2008;68:1204-1212.
21. Yasui H, Hideshima T, Raje N, Roccaro AM, Shiraishi N, Kumar S, Hamasaki M, Ishitsuka K, Tai YT, Podar K, Catley L, Mitsiades CS, Richardson PG, Albert R, Brinkmann V, Chauhan D, Anderson KC: FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance. Cancer Res 2005;65:7478-7484.
22. Matsuda S, Minowa A, Suzuki S, Koyasu S: Differential activation of c-Jun NH2-terminal kinase and p38 pathways during FTY720-induced apoptosis of T lymphocytes that is suppressed by the extracellular signal-regulated kinase pathway. J Immunol 1999;162:3321-3326.
23. Matsuoka Y, Nagahara Y, Ikekita M, Shinomiya T: A novel immunosuppres-sive agent FTY720 induced Akt dephos-phorylation in leukemia cells. Br J Pharmacol 2003;138:1303-1312.
24. Permpongkosol S, Wang JD, Takahara S, Matsumiya K, Nonomura N, Nishimura K, Tsujimura A, Kongkanand A, Okuyama A: Anticarcinogenic effect of FTY720 in human prostate carcinoma DU145 cells: modulation of mitogenic signaling, FAK, cell-cycle entry and apoptosis. Int J Cancer 2002;98:167-172.
25. Chua CW, Lee DT, Ling MT, Zhou C, Man K, Ho J, Chan FL, Wang X, Wong YC: FTY720, a fungus metabolite, inhibits in vivo growth of androgen-inde-pendent prostate cancer. Int J Cancer 2005;117:1039-1048.
26. Wang JD, Takahara S, Nonomura N, Ichimaru N, Toki K, Azuma H, Matsumiya K, Okuyama A, Suzuki S: Early induction of apoptosis in andro-gen-independent prostate cancer cell line by FTY720 requires caspase-3 activation. Prostate 1999;40:50-55.
27. Ubai T, Azuma H, Kotake Y, Inamoto T, Takahara K, Ito Y, Kiyama S, Sakamoto T, Horie S, Muto S, Takahara S, Otsuki Y, Katsuoka Y: FTY720 induced Bcl-as-sociated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft. Anticancer Res 2007;27:75-88.
28. Shen Y, Cai M, Xia W, Liu J, Zhang Q, Xie H, Wang C, Wang X, Zheng S: FTY720, a synthetic compound from Isaria sinclairii, inhibits proliferation and induces apoptosis in pancreatic cancer cells. Cancer Lett 2007;254:288-297.
29. Azuma H, Horie S, Muto S, Otsuki Y, Matsumoto K, Morimoto J, Gotoh R, Okuyama A, Suzuki S, Katsuoka Y, Takahara S: Selective cancer cell apoptosis induced by FTY720; evidence for a Bcl-dependent pathway and impairment in ERK activity. Anticancer Res 2003;23:3183-3193.
30. Brinkmann V, Wilt C, Kristofic C, Nikolova Z, Hof RP, Chen S, Albert R, Cottens S: FTY720: dissection of membrane receptor-operated, stereospecific effects on cell migration from receptor-independent antiproliferative and apoptotic effects. Transplant Proc 2001;33:3078-3080.
31. Li D, Zhang Y, Hu X, Cao W, Huang W: Role of extracellular regulated protein kinases in FTY720-induced apoptosis of leukemia cell lines HL-60 and U937. J Huazhong Univ Sci Technolog Med Sci 2004;24:45-47.
32. Nagaoka Y, Otsuki K, Fujita T, Uesato S: Effects of phosphorylation of immunomodulatory agent FTY720 (fingolimod) on antiproliferative activity against breast and colon cancer cells. Biol Pharm Bull 2008;31:1177-1181.
33. Lee TK, Man K, Ho JW, Sun CK, Ng KT, Wang XH, Wong YC, Ng IO, Xu R, Fan ST: FTY720 induces apoptosis of human hepatoma cell lines through PI3-K-me-diated Akt dephosphorylation. Carcino-genesis 2004;25:2397-2405.
34. Zhou C, Ling MT, Kin-Wah Lee T, Man K, Wang X, Wong YC: FTY720, a fungus metabolite, inhibits invasion ability of androgen-independent prostate cancer cells through inactivation of RhoA-GTPase. Cancer Lett 2006;233:36-47.
35. Nagahara Y, Ikekita M, Shinomiya T: Immunosuppressant FTY720 induces apoptosis by direct induction of permeability transition and release of cyto-chrome c from mitochondria. J Immunol 2000;165:3250-3259.
36. Coelho RP, Payne SG, Bittman R, Spiegel S, Sato-Bigbee C: The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors. J Pharmacol Exp Ther 2007;323:626-635.
37. Ishii I, Friedman B, Ye X, Kawamura S, McGiffert C, Contos JJ, Kingsbury MA, Zhang G, Brown JH, Chun J: Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)/EDG-3. J Biol Chem 2001;276:33697-33704.
38. Andreani P, Graler MH: Comparative quantification of sphingolipids and analogs in biological samples by high-performance liquid chromatography after chloroform extraction. Anal Biochem 2006;358:239-246.
39. Hammer S, Sauer B, Spika I, Schraut C, Kleuser B, Schafer-Korting M: Glucocorticoids mediate differential anti-apoptotic effects in human fibroblasts and keratinocytes via sphingosine-1-phosphate formation. J Cell Biochem 2004;91:840-851.
40. Keller CD, Rivera Gil P, Tolle M, van der Giet M, Chun J, Radeke HH, Schafer-Korting M, Kleuser B: Immunomodulator FTY720 induces myofibroblast differentiation via the lysophospholipid receptor S1P3 and Smad3 signaling. Am J Pathol 2007;170:281-292.
41. Radeff-Huang J, Seasholtz TM, Matteo RG, Brown JH: G protein mediated signaling pathways in lysophospholipid induced cell proliferation and survival. J Cell Biochem 2004;92:949-966.
42. Suzuki S, Li XK, Enosawa S, Shinomiya T: A new immunosuppressant, FTY720, induces bcl-2-associated apoptotic cell death in human lymphocytes. Immunology 1996;89:518-523.
43. Shinomiya T, Li XK, Amemiya H, Suzuki S: An immunosuppressive agent, FTY720, increases intracellular concentration of calcium ion and induces apoptosis in HL-60. Immunology 1997;91:594-600.
44. Sonoda Y, Yamamoto D, Sakurai S, Hasegawa M, Aizu-Yokota E, Momoi T, Kasahara T: FTY720, a novel immuno-suppressive agent, induces apoptosis in human glioma cells. Biochem Biophys Res Commun 2001;281:282-288.
45. Ho JW, Man K, Sun CK, Lee TK, Poon RT, Fan ST: Effects of a novel immunomodulating agent, FTY720, on tumor growth and angiogenesis in hepa-tocellular carcinoma. Mol Cancer Ther 2005;4:1430-1438.
46. Tedesco-Silva H, Mourad G, Kahan BD, Boira JG, Weimar W, Mulgaonkar S, Nashan B, Madsen S, Charpentier B, Pellet P, Vanrenterghem Y: FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation. Transplantation 2004;77:1826-1833.
47. Nikolova Z, Hof RP: Neointima suppression in rat carotid allografts by FTY720 combined with a small fixed cyclosporine dose is related to a diminution of the peripheral lymphocyte count. Transplant Proc 2001;33:2184-2185.
48. Sanchez T, Estrada-Hernandez T, Paik JH, Wu MT, Venkataraman K, Brinkmann V, Claffey K, Hla T: Phos-phorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. J Biol Chem 2003;278:47281-47290.
49. Means CK, Xiao CY, Li Z, Zhang T, Omens JH, Ishii I, Chun J, Brown JH: Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2007;292:H2944-2951.
50. Fieber CB, Eldridge J, Taha TA, Obeid LM, Muise-Helmericks RC: Modulation of total Akt kinase by increased expression of a single isoform: requirement of the sphingosine-1-phosphate receptor, Edg3/S1P3, for the VEGF-dependent expression of Akt3 in primary endothe-lial cells. Exp Cell Res 2006;312:1164-1173.
51. Ramos JW: The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. Int J Biochem Cell Biol 2008;40:2707-2719.
52. Bohler T, Kamar N, Etienne L, Galvani S, Canivet C, Thomsen M, Salvayre R, Nègre-Salvayre A, Rostaing L, Auge N: FTY720 Inhibits Tumor Necrosis Factor-alpha-Induced Proliferation and Extracellular Signal-Regulated Kinase Phos-phorylation of Human Smooth Muscle Cells. Transplant Proc 2009;41:705-706.
53. Osinde M, Mullershausen F, Dev KK: Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors. Neuropharmacology 2007;52:1210-1218.
54. Burgering BM, Coffer PJ: Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 1995;376:599-602.
55. Vivanco I, Sawyers CL: The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2002;2:489-501.
56. Baudhuin LM, Jiang Y, Zaslavsky A, Ishii I, Chun J, Xu Y: S1P3-mediated Akt activation and cross-talk with platelet-derived growth factor receptor (PDGFR). Faseb J 2004;18:341-343.
57. Memmott RM, Dennis PA: Akt-depend-ent and-independent mechanisms of mTOR regulation in cancer. Cell Signal 2009;21:656-664.
58. Chung T, Crilly KS, Anderson WH, Mukherjee JJ, Kiss Z: ATP-dependent choline phosphate-induced mitogenesis in fibroblasts involves activation of pp70 S6 kinase and phosphatidylinositol 3'-kinase through an extracellular site. Synergistic mitogenic effects of choline phosphate and sphingosine 1-phosphate. J Biol Chem 1997;272:3064-3072.
59. Huang JS, Mukherjee JJ, Kiss Z: Ethanol potentiates the mitogenic effects of sphingosine 1-phosphate by a zinc-and calcium-dependent mechanism in fibroblasts. Arch Biochem Biophys 1999;366:131-138.
60. Kluk MJ, Hla T: Role of the sphingosine 1-phosphate receptor EDG-1 in vascular smooth muscle cell proliferation and migration. Circ Res 2001;89:496-502.
61. Fujino M, Li XK, Guo L, Kitazawa Y, Funeshima N, Fukuda S, Kimura H, Miyashita T, Okuyama T, Amano T, Suzuki S: T-cell apoptosis triggered by FTY720 via mitochondrial pathway. Transplant Proc 2001;33:3084-3085.
62. Nagahara Y, Ikekita M, Shinomiya T: T cell selective apoptosis by a novel im-munosuppressant, FTY720, is closely regulated with Bcl-2. Br J Pharmacol 2002;137:953-962.
63. Weigert A, Johann AM, von Knethen A, Schmidt H, Geisslinger G, Brune B: Apoptotic cells promote macrophage survival by releasing the antiapoptotic mediator sphingosine-1-phosphate. Blood 2006;108:1635-1642.
64. Nieuwenhuis B, Lüth A, Kleuser B: Dex-amethasone protects human fibroblasts from apoptosis via an S1P(3)-receptor subtype dependent activation of PKB/Akt and Bcl(XL). Pharmacol Res 2010;61:449-459.
65. Manggau M, Kim DS, Ruwisch L, Vogler R, Korting HC, Schafer-Korting M, Kleuser B: 1Alpha,25-dihydroxyvitamin D3 protects human keratinocytes from apoptosis by the formation of sphingo-sine-1-phosphate. J Invest Dermatol 2001;117:1241-1249.